Report Overview
Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2014
Summary
GlobalData's clinical trial report, “Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2014" provides data on the Chagas Disease (American Trypanosomiasis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chagas Disease (American Trypanosomiasis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chagas Disease (American Trypanosomiasis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table Of Contents
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Chagas Disease (American Trypanosomiasis) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Chagas Disease (American Trypanosomiasis) to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Chagas Disease (American Trypanosomiasis) to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Merck & Co., Inc. 28
Clinical Trial Overview of Merck & Co., Inc. 28
Bayer AG 29
Clinical Trial Overview of Bayer AG 29
Clinical Trial Overview of Top Institutes / Government 30
Drugs for Neglected Diseases initiative 30
Clinical Trial Overview of Drugs for Neglected Diseases initiative 30
Hospital de Nios R. Gutierrez de Buenos Aires 31
Clinical Trial Overview of Hospital de Nios R. Gutierrez de Buenos Aires 31
Hospital Sao Rafael 32
Clinical Trial Overview of Hospital Sao Rafael 32
National Heart, Lung, and Blood Institute 33
Clinical Trial Overview of National Heart, Lung, and Blood Institute 33
Centre de Recerca en Salut Internacional de Barcelona 34
Clinical Trial Overview of Centre de Recerca en Salut Internacional de Barcelona 34
Universidade Federal da Bahia 35
Clinical Trial Overview of Universidade Federal da Bahia 35
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 36
Clinical Trial Overview of Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 36
Institut Recerca Hospital Universitari Vall d'Hebron 37
Clinical Trial Overview of Institut Recerca Hospital Universitari Vall d'Hebron 37
Oswaldo Cruz Foundation 38
Clinical Trial Overview of Oswaldo Cruz Foundation 38
Tulane University 39
Clinical Trial Overview of Tulane University 39
Five Key Clinical Profiles 40
Appendix 61
Abbreviations 61
Definitions 61
Research Methodology 62
Secondary Research 62
About GlobalData 63
Contact Us 63
Disclaimer 63
Source 63
List Of Tables
List of Tables
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 12
Proportion of Chagas Disease (American Trypanosomiasis) to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Chagas Disease (American Trypanosomiasis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Chagas Disease (American Trypanosomiasis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Chagas Disease (American Trypanosomiasis) to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Chagas Disease (American Trypanosomiasis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Chagas Disease (American Trypanosomiasis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Chagas Disease (American Trypanosomiasis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 28
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 29
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Drugs for Neglected Diseases initiative, 2014* 30
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital de Nios R. Gutierrez de Buenos Aires, 2014* 31
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Sao Rafael, 2014* 32
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 33
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre de Recerca en Salut Internacional de Barcelona, 2014* 34
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidade Federal da Bahia, 2014* 35
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal, 2014* 36
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Recerca Hospital Universitari Vall d'Hebron, 2014* 37
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oswaldo Cruz Foundation, 2014* 38
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tulane University, 2014* 39
List Of Figures
List of Figures
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 12
Proportion of Chagas Disease (American Trypanosomiasis) to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Chagas Disease (American Trypanosomiasis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Chagas Disease (American Trypanosomiasis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Chagas Disease (American Trypanosomiasis) to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Chagas Disease (American Trypanosomiasis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Chagas Disease (American Trypanosomiasis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Chagas Disease (American Trypanosomiasis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 62